By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Tesaro, Inc. (Boston, Massachusetts) 

135 Clarendon Street #14R

Boston  Massachusetts  02116  U.S.A.
Phone: n/a Fax: n/a


Company News
A Biotech Binary Event Playbook: How To Play Clovis Oncology (CLVS) And Tesaro (TSRO) Ahead Of Label Decision 8/9/2017 8:45:38 AM
Not-Yet Sold Tesaro (TSRO) Bags $340 Million Cancer Deal With Pharma Giant Takeda (TKPYY) 7/27/2017 6:15:44 AM
Will Tesaro (TSRO) Be The Focus Of The Next Biotech Bidding War? 6/14/2017 6:17:08 AM
Why Sought-After Tesaro (TSRO)'s Rumored Sale Could Bring in $200 Per Share 2/13/2017 6:14:32 AM
Massachusetts' Tesaro (TSRO) Being Wooed by Multiple Suitors 2/9/2017 5:40:10 AM
Clinigen Release: Company Initiates U.S. Managed Access Program For Tesaro (TSRO)’s Niraparib For Patients With Ovarian Cancer 1/17/2017 11:31:14 AM
What's PARP? Meet Two of Biotech's Newest M&A Targets: Tesaro (TSRO) and Clovis Oncology (CLVS) 9/15/2016 6:33:52 AM
Drugmaker Tesaro (TSRO) Raises $377M in Public Stock Offering 6/30/2016 11:54:36 AM
ASCO2016: Tesaro (TSRO) Provides Pipeline Update At ASCO Investor Briefing 6/6/2016 2:19:56 PM
10 Biotech Stocks Analysts are Upbeat About in May 5/23/2016 8:24:58 AM